A. Chuchalin (Moscow, Russian Federation), M. Maniscalco (Napoli, Italy)
Undiagnosed and untreated rhythm disturbances and arterial hypertension in development of chronic obstructive lung disease exacerbation
L. V. Rasputina, Y. M. Mostovoy, N. S. Slepchenko (Vinnitsa, Ukraine)
|  |
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
M. Ridha, Y. Ferdaous, T. Sofia, C. Amel, B. K. Ali (Ariana, Tunisia)
| |
Long time follow-up of progressive airflow obstruction after bone marrow and stem cell transplantation
C. Lambers, C. Hussein, B. Nadler, S. Woehrer, L. H. Block, W. Rabitsch (Vienna, Austria)
| |
Retrospective analysis of characteristics and costs of hospital treatment of chronic obstructive pulmonary disease exacerbations
M. Merino, I. Alfageme, N. Reyes, J. Lima, F. Pichardo (Seville, Spain)
| |
The food frequency in patients with chronic obstructive pulmonary disease: effect of exacerbation of disease
S. V. Raljevic (Belgrade, Serbia And Montenegro)
| |
Cardiovascular risk factors in patients with chronic obstructive pulmonary disease
S. Bilgin, S. Gungor, M. Yalcinsoy, E. Tekiner, E. Akkaya (Istanbul, Turkey)
| |
Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate
P. Kapisyzi, D. Argjiri (Tirana, Albania)
| |
The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease
E. A. Petukhova, J. N. Krasnova, A. A. Dzizinskii (Irkutsk, Russian Federation)
| |
Evaluation of metabolic profile in patients with chronic obstructive pulmonary disease and correlation between the metabolic parameters and the severity of disease
C. L. Toma, I. Pele, C. Camburu, M. S. Mitrache, S. Dumitrache-Rujinski, C. E. Tudose, D. Bumbacea, M. A. Bogdan (Bucharest, Romania)
| |
Prevalence of chronic obstructive pulmonary disease in a series of smoker patients from Rio de Janeiro, Brazil
M. C. Kaisermann (Rio de Janeiro, Brazil)
| |
Inpatient acute exacerbations of chronic obstructive pulmonary disease clinical pathway: development and initial experience
K. Nishimura, M. Hashimoto, T. Nakano, S. Itoh, K. Tamura, T. Yoshimura, N. Yamashita, T. Hanawa, Y. Matsubara, T. Oga (Kyoto, Japan)
| |
Activity of proteinase-inhibitor enzymes and secretory sIg A of patients with chronic obctructive pulmonary disease in bronchoalveolar lavage fluid
T. A. Pertseva, O. B. Pavlenko (Dniepropetrovsk, Ukraine)
| |
Is chronic obstructive pulmonary disease a risk factor for the development of lower urinary tract symptoms?
E. Gulec, A. Kayikci, O. Balbay, O. Akyuz, A. N. Annakkaya, K. Cam, P. Arbak (Duzce, Turkey)
| |
Comparative evaluation of different methods of correction of mucociliary transport (MCT) insufficiency in patients with chronic bronchitis (CB)
O. V. Gurzhiy (Dnepropetrovsk, Ukraine)
| |
Exhaled hydrogen peroxide in patients with stable chronic obstructive pulmonary disease: effect of cigarette smoking
E. Anaev, E. Kuritsyna, A. Karyakin, A. Chuchalin (Moscow, Russian Federation)
| |
Body composition and pulmonary function in patients with chronic obstructive pulmonary disease
I. V. Cekerevac, Z. M. Lazic, L. A. Novkovic, M. A. Petrovic, V. M. Bosnjak-Petrovic (Kragujevac, Beograd, Serbia And Montenegro)
| |
Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients
V. K. Gavrisyuk, N. I. Gumenyuk, Y. A. Dzyublik, N. D. Morskaya (Kiev, Ukraine)
| |
Chronic obstructive pulmonary disease: real opportunity of 3 year respiratory function control
I. Y. Vizel, E. A. Vizel, A. A. Vizel, E. Y. Pronina (Kazan, Russian Federation)
| |
Characteristics of adults dying from obstructive lung disease
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |